Article
Evaluating the efficacy of GIPR agonists on non-alcoholic fatty liver disease: A Mediation Mendelian Randomization Study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 1 Oct 2024
Xie Siyuan, Chen Delong, Cai Yangke, Xu Liyi, Liao Oulan, Jia Xuan, Ji Xiaowei, Chen Hanwen, Mao Jianshan, Cai Jianting
Abstract excerpt
OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease worldwide while still lacks drugs for treatment or prevention. We aimed to investigate the causal role of glucose-dependent insulinotropic polypeptide receptor agonists (GIPRAs) on NAFLD and identify the mediated risk factors by which GIPRAs exert their therapeutic effects. METHODS: Genetic proxies of GIPRAs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
